Back to search

Article

Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release

2022-02-09

Abstract excerpt

<h4>SUMMARY</h4> The Omicron variant has become dominant in the U.S. and around the world. This variant is found to be 2-fold more infectious than the Delta variant, posing a significant threat of severe cases and death. We and others have recently reported that the N-terminus domain (NTD) of the SARS-CoV-2 of various variants is responsible for inducing cytokine release in human PBMCs. Here, we demonstrate that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2de5bcfc-ef94-5b90-9ac2-6db009abe6c6
DOI
10.1101/2022.02.07.479443
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine releaseDOI 10.1101/2022.02.07.479443
Machine Learning Identifies Ponatinib as a Potent Inhibitor of SARS-CoV2-induced Cytokine StormSemantic proximity
Omicron-Enhanced Immunosuppressive Effects of SARS-CoV-2 ORF3a and ORF9b Accessory Proteins on Monocytic Inflammatory ResponseSemantic proximity
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variantsSemantic proximity
SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including OmicronSemantic proximity
Why SARS-CoV-2 Omicron variant is milder? A single high-frequency mutation of structural envelope protein mattersSemantic proximity
Dual Inhibition of Cathepsin L and 3CL-Pro by GC-376 Constrains SARS Cov2 Infection Including Omicron VariantSemantic proximity
SARS-CoV-2 Omicron spike H655Y mutation is responsible for enhancement of the endosomal entry pathway and reduction of cell surface entry pathwaysSemantic proximity
Computer-aided prediction of inhibitors against STAT3 for managing COVID-19 associate cytokine stormSemantic proximity
Select a neighboring publication to make it the new centre.